AIM To investigate whether gut microbiota metabolite sodium butyrate (NaB) is an effective substance for attenuating non-alcoholic fatty liver disease (NAFLD) and the internal mechanisms. METHODS Male C57BL/6J mice we...AIM To investigate whether gut microbiota metabolite sodium butyrate (NaB) is an effective substance for attenuating non-alcoholic fatty liver disease (NAFLD) and the internal mechanisms. METHODS Male C57BL/6J mice were divided into three groups, normal control were fed standard chow and model group were fed a high-fat diet (HFD) for 16 wk, the intervention group were fed HFD for 16 wk and treated with NaB for 8 wk. Gut microbiota from each group were detected at baseline and at 16 wk, liver histology were evaluated and gastrointestinal barrier indicator such as zonula occluden-1 (ZO-1) were detected by immunohistochemistry and realtime-PCR, further serum or liver endotoxin were determined by ELISA and inflammation-or metabolism-associated genes were quantified by real-time PCR. RESULTS NaB corrected the HFD-induced gut microbiota imbalance in mice, while it considerably elevated the abundances of the beneficial bacteria Christensenellaceae, Blautia and Lactobacillus. These bacteria can produce butyric acid in what seems like a virtuous circle. And butyrate restored HFD induced intestinal mucosa damage, increased the expression of ZO-1 in small intestine, further decreased the levels of gut endotoxin in serum and liver compared with HF group. Endotoxin-associated genes such as TLR4 and Myd88, pro-inflammation genes such as MCP-1, TNF-alpha, IL-1, IL-2, IL-6 and IFN-gamma in liver or epididymal fat were obviously downregulated after NaB intervention. Liver inflammation and fat accumulation were ameliorated, the levels of TG and cholesterol in liver were decreased after NaB intervention, NAS score was significantly decreased, metabolic indices such as FBG and HOMA-IR and liver function indicators ALT and AST were improved compared with HF group. CONCLUSION NaB may restore the dysbiosis of gut microbiota to attenuate steatohepatitis, which is suggested to be a potential gut microbiota modulator and therapeutic substance for NAFLD.展开更多
Background Understanding the characteristics of Chinese dialysis patients and the current practice trends is the first step to evaluate the association between practice pattern and outcome in these populations. In the...Background Understanding the characteristics of Chinese dialysis patients and the current practice trends is the first step to evaluate the association between practice pattern and outcome in these populations. In the present study, we evaluated the status of medical treatment and characteristic features of chronic dialysis patients in China. Methods Through a clustering sampling, we selected 9 centers from the largest dialysis facilities in 6 cities around China. All adult undergoing dialysis in the selected units were screened. A total of 2388 （1775 on hemodialysis （HD） and 613 on peritoneal dialysis （PD）） patients were finally enrolled. All data were collected at enrollment on the bases of review of medical records. Results In this cohort, 1313 （55.0%） were male. The mean age was 54 years old. The median time for dialysis was 26 months （12-51 months）. Seventy-five percent of patients were on HD and 25.0% on PD. Among PD patients, about 21% patients did not receive dialysis adequacy. For HD patients, about 14.0% of them did not achieve dialysis adequacy when the target of kt/V was set as 1.2. Only 44.7% of patients achieved blood pressure target of 140/90 mmHg. About 60% of patients did not reach the hemoglobin target of 110 g/L even though 85.0% of them were treated with erythropoietin. In addition, 48.5% of the patients had uncontrolled mineral metabolism revealed by the high calcium-phosphate product. Compared with HD patients, higher level of serum glucose, triglyceride, and total and low density lipoprotein cholesterol were more common in PD patients. Conclusions This observational study suggests that many Chinese dialysis patients did not achieve the therapeutic target, particularly in blood pressure control, anemia correction, and mineral balance. PD patients were more likely to suffer metabolic disturbance.展开更多
1概述肺癌是最常见的恶性肿瘤之一,在世界各地,肺癌均居恶性肿瘤死亡构成比的第一位,其发病率和死亡率仍在不断升高。据世界卫生组织（World Health Organization,WHO）下属的国际癌症研究机构（International Agency for Research on C...1概述肺癌是最常见的恶性肿瘤之一,在世界各地,肺癌均居恶性肿瘤死亡构成比的第一位,其发病率和死亡率仍在不断升高。据世界卫生组织（World Health Organization,WHO）下属的国际癌症研究机构（International Agency for Research on Cancer,IARC）出版的GLOBOCAN 2012估计：全世界肺癌新发病例1 8 2.5万（男性124.2万,女性58.3万）.展开更多
INTRODUCTIONThe prevalence of hyperuricenlia （HUA） has increased in China in the recent years in relation to socioeconomic developments and changing lifestyles and diets, with a trend toward onset at younger age. HU...INTRODUCTIONThe prevalence of hyperuricenlia （HUA） has increased in China in the recent years in relation to socioeconomic developments and changing lifestyles and diets, with a trend toward onset at younger age. HUA has become the second most common metabolic disease after diabetes mellitus. Like gout, HUA is also associated with the occurrence and progression of disorders of the urinary, endocrine, metabolic, cardio-cerebrovascular, and other systems.展开更多
AIM: To evaluate the efficacy and safety of tolvaptan to treat refractory ascites in decompensated liver cirrhosis patients with or without further complications, such as hepatorenal syndrome and/or hepatocellular car...AIM: To evaluate the efficacy and safety of tolvaptan to treat refractory ascites in decompensated liver cirrhosis patients with or without further complications, such as hepatorenal syndrome and/or hepatocellular carcinoma.展开更多
【目的】了解灯盏花[Erigeron breviscapus(Vant.)Hand-Mazz]叶绿体基因组密码子的使用偏好性。【方法】以灯盏花叶绿体基因组全序列为研究对象,利用CodonW 1.4.2软件和CUSP程序等对筛选出的47条CDS(coding DNA sequence)进行分析,并进...【目的】了解灯盏花[Erigeron breviscapus(Vant.)Hand-Mazz]叶绿体基因组密码子的使用偏好性。【方法】以灯盏花叶绿体基因组全序列为研究对象,利用CodonW 1.4.2软件和CUSP程序等对筛选出的47条CDS(coding DNA sequence)进行分析,并进行中性绘图、ENC-plot绘图和PR2-plot绘图分析。【结果】叶绿体基因组密码子中不同位置的GC碱基含量比值为GC_1>GC_2>GC_3,说明密码子末位碱基偏性以A/T(U)结尾;有效密码子数的均值为47.18,密码子使用偏性较弱;3种绘图分析结果发现:影响灯盏花叶绿体基因组密码子偏好性的主要因素是自然选择,也受到其他因素(如突变)的影响;最优密码子分析中确定了UUU、UUA和UUG等18个最优密码子,且大多数以A和U结尾,有且仅有1个以G结尾。【结论】灯盏花叶绿体基因组密码子第3位偏好性以A或U碱基结尾,密码子使用模式受选择和其他因素共同影响,其中选择的作用较大。该结果可为后续利用基因工程手段对外源基因密码子改造、提高所转基因在灯盏花叶绿体中的表达提供参考。展开更多
基金the State Key Development Program for Basic Research of China,No.2012CB517501National Natural Science Foundation of China,No.81070322,No.81270491,No.81470840 and No.31400001100 Talents Program,No.XBR2011007h
文摘AIM To investigate whether gut microbiota metabolite sodium butyrate (NaB) is an effective substance for attenuating non-alcoholic fatty liver disease (NAFLD) and the internal mechanisms. METHODS Male C57BL/6J mice were divided into three groups, normal control were fed standard chow and model group were fed a high-fat diet (HFD) for 16 wk, the intervention group were fed HFD for 16 wk and treated with NaB for 8 wk. Gut microbiota from each group were detected at baseline and at 16 wk, liver histology were evaluated and gastrointestinal barrier indicator such as zonula occluden-1 (ZO-1) were detected by immunohistochemistry and realtime-PCR, further serum or liver endotoxin were determined by ELISA and inflammation-or metabolism-associated genes were quantified by real-time PCR. RESULTS NaB corrected the HFD-induced gut microbiota imbalance in mice, while it considerably elevated the abundances of the beneficial bacteria Christensenellaceae, Blautia and Lactobacillus. These bacteria can produce butyric acid in what seems like a virtuous circle. And butyrate restored HFD induced intestinal mucosa damage, increased the expression of ZO-1 in small intestine, further decreased the levels of gut endotoxin in serum and liver compared with HF group. Endotoxin-associated genes such as TLR4 and Myd88, pro-inflammation genes such as MCP-1, TNF-alpha, IL-1, IL-2, IL-6 and IFN-gamma in liver or epididymal fat were obviously downregulated after NaB intervention. Liver inflammation and fat accumulation were ameliorated, the levels of TG and cholesterol in liver were decreased after NaB intervention, NAS score was significantly decreased, metabolic indices such as FBG and HOMA-IR and liver function indicators ALT and AST were improved compared with HF group. CONCLUSION NaB may restore the dysbiosis of gut microbiota to attenuate steatohepatitis, which is suggested to be a potential gut microbiota modulator and therapeutic substance for NAFLD.
基金This work was supported by the grants from the National 973 Program （No. 2012CB517703 and No. 2011CB504005）, the National Natural Science Foundation of China （No. U0932002）, and the Public Welfare and Health Sector Research Project （No. 201002010）.
文摘Background Understanding the characteristics of Chinese dialysis patients and the current practice trends is the first step to evaluate the association between practice pattern and outcome in these populations. In the present study, we evaluated the status of medical treatment and characteristic features of chronic dialysis patients in China. Methods Through a clustering sampling, we selected 9 centers from the largest dialysis facilities in 6 cities around China. All adult undergoing dialysis in the selected units were screened. A total of 2388 （1775 on hemodialysis （HD） and 613 on peritoneal dialysis （PD）） patients were finally enrolled. All data were collected at enrollment on the bases of review of medical records. Results In this cohort, 1313 （55.0%） were male. The mean age was 54 years old. The median time for dialysis was 26 months （12-51 months）. Seventy-five percent of patients were on HD and 25.0% on PD. Among PD patients, about 21% patients did not receive dialysis adequacy. For HD patients, about 14.0% of them did not achieve dialysis adequacy when the target of kt/V was set as 1.2. Only 44.7% of patients achieved blood pressure target of 140/90 mmHg. About 60% of patients did not reach the hemoglobin target of 110 g/L even though 85.0% of them were treated with erythropoietin. In addition, 48.5% of the patients had uncontrolled mineral metabolism revealed by the high calcium-phosphate product. Compared with HD patients, higher level of serum glucose, triglyceride, and total and low density lipoprotein cholesterol were more common in PD patients. Conclusions This observational study suggests that many Chinese dialysis patients did not achieve the therapeutic target, particularly in blood pressure control, anemia correction, and mineral balance. PD patients were more likely to suffer metabolic disturbance.
文摘1概述肺癌是最常见的恶性肿瘤之一,在世界各地,肺癌均居恶性肿瘤死亡构成比的第一位,其发病率和死亡率仍在不断升高。据世界卫生组织（World Health Organization,WHO）下属的国际癌症研究机构（International Agency for Research on Cancer,IARC）出版的GLOBOCAN 2012估计：全世界肺癌新发病例1 8 2.5万（男性124.2万,女性58.3万）.
文摘INTRODUCTIONThe prevalence of hyperuricenlia （HUA） has increased in China in the recent years in relation to socioeconomic developments and changing lifestyles and diets, with a trend toward onset at younger age. HUA has become the second most common metabolic disease after diabetes mellitus. Like gout, HUA is also associated with the occurrence and progression of disorders of the urinary, endocrine, metabolic, cardio-cerebrovascular, and other systems.
基金Supported by The Program of Beijing Science and Technology Commission,No.D131100005313004the Beijing HighLevel Talent Academic Leader/Personnel Training Programs awarded to Ding HG,2011-2-19+1 种基金Li B,2013-3-072and Li L,2013-3-073
文摘AIM: To evaluate the efficacy and safety of tolvaptan to treat refractory ascites in decompensated liver cirrhosis patients with or without further complications, such as hepatorenal syndrome and/or hepatocellular carcinoma.
文摘【目的】了解灯盏花[Erigeron breviscapus(Vant.)Hand-Mazz]叶绿体基因组密码子的使用偏好性。【方法】以灯盏花叶绿体基因组全序列为研究对象,利用CodonW 1.4.2软件和CUSP程序等对筛选出的47条CDS(coding DNA sequence)进行分析,并进行中性绘图、ENC-plot绘图和PR2-plot绘图分析。【结果】叶绿体基因组密码子中不同位置的GC碱基含量比值为GC_1>GC_2>GC_3,说明密码子末位碱基偏性以A/T(U)结尾;有效密码子数的均值为47.18,密码子使用偏性较弱;3种绘图分析结果发现:影响灯盏花叶绿体基因组密码子偏好性的主要因素是自然选择,也受到其他因素(如突变)的影响;最优密码子分析中确定了UUU、UUA和UUG等18个最优密码子,且大多数以A和U结尾,有且仅有1个以G结尾。【结论】灯盏花叶绿体基因组密码子第3位偏好性以A或U碱基结尾,密码子使用模式受选择和其他因素共同影响,其中选择的作用较大。该结果可为后续利用基因工程手段对外源基因密码子改造、提高所转基因在灯盏花叶绿体中的表达提供参考。
